Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile

Genes and Nutrition

Volumn 8, Issue 6, 2013, Pages 561-569

  Serrano, Jose C E ^a   De Lorenzo, David ^a   Cassanye, Anna ^a   Martín Gari, Meritxell ^a   Espinel, Alberto ^b   Delgado, Marco Antonio ^b   Pamplona, Reinald ^a   Portero Otin, Manuel ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b Instituto Tomás   (Spain)

Author keywords

Lipid profile; Soy; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; VITAMIN BLOOD LEVEL; VITAMIN D RECEPTOR GENE;

EID: 84887246006     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-013-0356-4     Document Type: Article

References (34)

1. Anderson JW, Bush HM (2011) Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 30:79-91
2. Anderson PH, O'Loughlin PD, May BK, Morris HA (2004) Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 89-90:111-113
3. Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD (2008) Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 391:1917-1930
4. Audí L, Martí G, Esteban C, Oyarzabal M, Chueca M, Gussinyé M, Yeste D, Fernández-Cancio M, Andaluz P, Carrascosa A (2004) VDR gene polymorphism at exon 2 start codon (Fokl) may have influenced Type 1 diabetes mellitus susceptibility in two Spanish populations [1]. Diabet Med 21:393-394
5. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, Willett WC (2007) Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85:735-741
6. Capoluongo E, Pitocco D, Concolino P, Santonocito C, Di Stasio E, d'Onofrio G, Manto A, Giardina B, Ghirlanda G, Ameglio F, Zuppi C (2006) Slight association between type 1 diabetes and "ff" VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 39:888-892
7. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Akerstrom G, Melhus H (1995) Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1:1309-1311
8. Chang T-, Lei H-, Yeh J-, Chiu KC, Lee K-, Chen M-, Tai T-, Chuang L- (2000) Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf) 52:575-580
9. Cross HS, Kállay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ (2004) Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 134:1207S-1212S
10. Decker CJ, Parker R (1995) Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr Opin Cell Biol 7:386-392
11. García D, Angel B, Carrasco E, Albala C, Santos JL, Pérez-Bravo F (2007) VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Res Clin Pract 77:134-140
12. Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, Zunft H-F, Ferrari M, Branca F, Dadd T, Talbot D, Powell J, Minihane A-, Cassidy A, Nilsson M, Dahlman-Wright K, Gustafsson J-, Williams CM (2006) Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83:592-600
13. Hermansen K, Hansen B, Jacobsen R, Clausen P, Dalgaard M, Dinesen B, Holst JJ, Pedersen E, Astrup A (2005) Effects of soy supplementation on blood lipids and arterial function in hypercholesterolemic subjects. Eur J Clin Nutr 59:843-850
14. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A (2009) Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 15:423-440
15. Jacobs DM, Gaudier E, van Duynhoven J, Vaughan EE (2009) Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr Drug Metab 10:41-54
16. Ko T-F, Tsai H-S, Lin S-M, Liu C-D, Learn S-P, Chiou RY (2010) GC-MS determined distribution of urinary equol producers as affected by age, gender, and repeated ingestions of soymilk. J Food Sci 75:H306-H310
17. Liu ZM, Chen Y-, Ho SC (2011) Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 93:1092-1101
18. Makariou S, Liberopoulos EN, Elisaf M, Challa A (2011) Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med 22:355-362
19. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichtenstein AH (2007) Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 85:960-966
20. McGuigan FEA, Ralston SH (2002) Single nucleotide polymorphism detection: allelic discrimination using TaqMan. Psychiatr Genet 12:133-136
21. Miraghajani MS, Azadbakht L (2011) Can soy products affect on inflammation level? A review on the current evidence. J Isfahan Med Sch 29:1116-1128
22. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287
23. Muray S, Parisi E, Cardús A, Craver L, Fernández E (2003) Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects. J Hypertens 21:2069-2075
24. Ortlepp JR, Von Korff A, Hanrath P, Zerres K, Hoffmann R (2003) Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest 33:106-109
25. Panierakis C, Goulielmos G, Mamoulakis D, Petraki E, Papavasiliou E, Galanakis E (2009) Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin Immunol 133:276-281
26. Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW (2012) Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 126:270-277
27. Schöttker B, Ball D, Gellert C, Brenner H (2012) Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 12:708-718
28. Schwartz Z, Pedrozo HA, Sylvia VL, Gomez R, Dean DD, Boyan BD (2001) 1α,25-(OH)2D3 regulates 25-hydroxyvitamin D3 24R-hydroxylase activity in growth zone costochondral growth plate chondrocytes via protein kinase C. Calcif Tissue Int 69:365-372
29. Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Slama G, Reach G, Selam J- (2002) Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia 45:436-442
30. Torres N, Guevara-Cruz M, Granados J, Vargas-Alarcón G, González-Palacios B, Ramos-Barragan VE, Quiroz-Olguín G, Flores-Islas IM, Tovar AR (2009) Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects. Nutr Res (New York, N.Y.) 29:728-735
31. Vuolo L, Di Somma C, Faggiano A, Colao A (2012) Vitamin D and cancer. Front Endocrinol (Lausanne) 3:58
32. Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523:123-133
33. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM (2012) Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 97(10):3557-3568
34. Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W (2012) Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Eur J Clin Invest 42(11):1189-1196